Mesenchymal Stem Cells Improve Glycometabolism and Liver Regeneration in the Treatment of Post-hepatectomy Liver Failure
Conclusion: Mesenchymal stem cell transplantation could be use as a potential treatment for PHLF.
Introduction
Partial hepatectomy is an important treatment for benign and malignant liver diseases. Although the liver can be completely regenerated after partial excision or injury, at least 1/3 of the liver should be retained in most of the patients, and 40–50% should be retained in patients with parenchymal liver disease (Adams et al., 2013; Cieslak et al., 2014). Postoperative complications, such as acute post-hepatectomy liver failure (PHLF) or small liver syndrome, may occur when the scope of excision is too large or the remaining liver is inadequate to maintain normal liver function. As a serious challenge to patient survival, PHLF is the main cause of death after liver surgery (Schreckenbach et al., 2012; Asenbaum et al., 2018). Although surgery and postoperative care have been greatly improved, the incidence of PHLF is between 0.7 and 9% (van den Broek et al., 2008). Therefore, the treatment for PHLF is problematic and needs to be improved.
At present, the most effective therapy for PHLF is liver transplantation. Although liver transplantation has a beneficial therapeutic effect, the insufficient donor liver and the high cost of this operation limit the number of liver transplantations performed (Donnelly et al., 2016). Although symptomatic support therapy can help to prevent the progression of PHLF, it is unsatisfactory for preventing sequelae and improv...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
More News: Academia | Alternative and Complementary Therapies | Anesthesia | Anesthesiology | Arrhythmia | Biology | Biomedical Science | Biotechnology | Bone Graft | Brain | Brain Cancers | Breast Cancer | Breast Carcinoma | Bronchopulmonary Dysplasia | Cancer | Cancer & Oncology | Carbohydrates | Carcinoma | Cardiac Arrhythmia | Cardiology | Cervical Cancer | Chemistry | China Health | Colorectal Cancer | Complementary Medicine | Diabetes | Eating Disorders & Weight Management | Endocrinology | Epithelial Cancer | Fatty Liver Disease (FLD) | Gastroenteritis | Gastroenterology | Gastroschisis Repair | Genetics | Germany Health | Grants | Heart | Heart Disease | Heart Transplant | Hepatocellular Carcinoma | Insulin | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Laparotomy | Liver | Liver Cancer | Liver Disease | Liver Transplant | Lung Transplant | Medical Ethics | Melanoma | Men | Molecular Biology | Neurology | Neuroscience | Neurosurgery | Obesity | Pancreas | Pancreatic Cancer | Pathology | Penicillin | Physiology | Reproduction Medicine | Science | Skin Cancer | Statistics | Stem Cell Therapy | Stem Cells | Students | Study | Sugar | Taiwan Health | Transplants | Universities & Medical Training | Urology & Nephrology | USA Health